A study by researchers at Seoul National University Bundang Hospital (SNUBH) showed that the use of digital healthcare among older adults is poor, with half of the participants unable to install related applications despite smartphone use.Digital healthcare technology, including a wide range of heal
In a notable legal development, Hugel has secured a favorable outcome in its legal battles against the Ministry of Food and Drug Safety (MFDS) regarding the indirect export of Botulax, its botulinum toxin (BTX) products, which led to the revocation of its sales license. The Seoul Administrative Cour
Many Korean pharma and biotech companies posted record-breaking results last year. Still, those focusing on the vaccine business, including GC Biopharma and SK bioscience, performed relatively poorly as the Covid-19 pandemic eased to an endemic.According to GC Biopharma’s preliminary consolidated op
"Taking Sugatree is like catching two birds with one stone, as it offers both ease of administration and cost-effectiveness."Dong-A ST's employees at the Diabetes Division of the Marketing 2 team of the ETC Business Headquarters said so in unison.Sugatree XR Tablet is a diabetes treatment combinatio
Samsung Biologics said it has obtained the "Leadership A-"grade, the second highest of the eight grades, from Carbon Disclosure Project (CDP), a global sustainability assessment organization, for its climate change response efforts in 2023.The company stressed that it is the first in the domestic bi
Hanmi Pharm CEO Lim Jong-yoon, the eldest son of the late Lim Sung-ki, who founded the Hanmi Pharmaceutical Group, and his younger, Hanmi Science CEO Lim Jong-hoon, have announced their intention to change the management of Hanmi Science.They plan to form a new board of directors through the shareho
“Cardiothoracic surgery is 19.57 to 1, and general surgery is 3.4 to 1.”Of course, this is not the case in Korea. These were the competition rates for medical specialties in the U.K. in 2022. Unlike Korea, “vital departments” like cardiothoracic surgery and general surgery are popular among doctors
Handok said it decided to establish a local joint venture with Swedish Orphan Biovitrum (Sobi), a global biopharmaceutical company specializing in rare diseases, in the first half of this year.Sobi is a global biopharmaceutical company specializing in rare diseases, providing innovative treatments i
JW Pharmaceuticals announced on Tuesday that interim results from a study showcasing the efficacy and safety of Hemlibra (emicizumab) in hemophilia A patients younger than one year old were recently published in the international journal Blood.Dr. Steven Pipe, professor of pediatrics at the Universi
It's a new year, the time when many commit to living a healthier life. To succeed, remember this: focus on short-term goals rather than long-term ones. Humans often prioritize immediate benefits over future ones, a phenomenon known as preference reversal over time in behavioral economics.Dermatologi
Hugel said it showcased new clinical findings for its botulinum toxin (BTX) product at the 25th International Master Course on Aging Science (IMCAS) World Congress, held in Paris, France, from Feb. 1 to 3.The event, which is recognized as the world's largest conference on aesthetic plastic surgery,
The Ministry of Health and Welfare has dismissed as untrue claims that the increase in medical school enrollment quotas is for election purposes and that the government and medical community will adjust the size of the increase after the election.The ministry added that the increased medical school
Tevimbra (tislelizumab), an anti-PD-1 immunotherapy developed by BeiGene, has begun the process of seeking reimbursement in Korea.BeiGene's stance of supplying innovative new drugs at reasonable prices is drawing attention to whether it could alleviate the growing financial burden caused by high-pri
Yuhan Corp. will hold its annual shareholders' meeting next month and decide whether to reappoint Cho Wook-je as its president and CEO. Industry officials watch with interest whether Cho will serve another term.The company issued a public notice last Tuesday, announcing that it would hold its annual
Celltrion said it has completed its application for marketing authorization to the European Medicines Agency (EMA) for CT-P47, a biosimilar referencing Actemra.Roche's Actemra (ingredient: tocilizumab), known as RoActemra in Europe, is approved for a wide range of conditions, including rheumatoid ar
A new treatment has landed in Korea for moderate to severe active ulcerative colitis that has not responded adequately to standard treatments or biologics or has become unresponsive.Lilly Korea said Thursday that the interleukin-23 (IL-23) inhibitor Omvoh (mirikizumab) has received approval from the
Severance Hospital has succeeded in conducting Korea's first irreversible electroporation surgery technique on a 76-year-old liver cancer patient. The patient has since been discharged and is now resuming normal daily activities.IRE involves creating small gaps of about 2mm in the cancerous tissue b
Eutilex said Thursday that it has completed registering a patent for antibody therapy, “103,” in China.The patent for “103” was registered as "Anti-Human VSIG4 Antibody and Uses Thereof." Eutilex, which has completed patient registration in the U.S. and Russia, expects to expand its business territo
C-Biomex said Thursday that it has entered into a collaborative research agreement with MD Anderson Cancer Center to proceed with the U.S. investigational new drug (IND) application for its radiopharmaceutical therapy, CBT-001.CBT-001 targets CA-9 (Carbonic anhydrase 9), which is overexpressed in ki
OCI Holdings Chairman Lee Woo-hyun has reaffirmed the company's strategy to play a minimal role in the management of Hanmi Group following the upcoming integration with Hanmi Science.During an investor conference call on Wednesday, Chairman Lee stated that OCI Holdings intends to support Hanmi Group